The National Institutes of Health (NIH) released a request for information (RFI) that invites comments and suggestions from the public to help in the development of its new five-year strategic plan.

Despite increasing demand for life sciences research funding and larger budgets from Congress, access to the investigator research funding from the National Institutes of Health (NIH) is getting harder, according to data released May 31 by Michael Lauer, NIH deputy director for Extramural Research.  R01 grants, the oldest and predominant funding mechanism NIH uses to distribute project-specific research grants, are becoming larger in size and more exclusive in who receives the grants.

The National Institutes of Health (NIH) announced its first round of investments totaling $46 million under the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. The $46 million will support more than 100 investigator-led research projects in 15 states and several countries to support the development of new tools and technologies to understand neural circuit function and capture a dynamic view of the brain in action.

National Institute of Health (NIH) Director Francis S. Collins has accepted recommendations from an NIH working group that call for increased investment in the federal government’s effort to map and understand the human brain. Under the recommended plan, the initiative would receive $400 million each year between 2016-20, which would grow to $500 million a year for 2021-25. The BRAIN Initiative is a multi-agency effort, supported by NIH, Defense Advanced Research Projects Agency of the U.S. Department of Defense, National Science Foundation and Food and Drug Administration.

A pilot collaboration between the National Science Foundation (NSF) Innovation Corps (I-Corps™) and the National Institutes of Health (NIH) will offer a nine-week boot camp to help biomedical researchers bring their discoveries to market. Academic researchers and entrepreneurs who have received SBIR/STTR Phase One awards from participating NIH institutes may apply to the I-Corps at NIH™ for training in building scalable business models around their technologies.

The National Institutes of Health (NIH) is accepting applications for the Research Evaluation and Commercialization Hub (REACH) program to support proof-of-concept centers (Hubs) that facilitate and accelerate the translation of biomedical innovations into commercial products that improve patient care and enhance health. NIH intends to award approximately $9 million to institutions of higher education to establish three new REACH Hubs.

Although the U.S. National Institutes of Health may face decreased funding under the new presidential administration, recently published research in Science argues that public investments in biomedical research play an important role in driving private sector R&D. In an analysis of 365,380 grants awarded by the U.S.

One of the best ways to measure the effectiveness of state programs intended to encourage the success of SBIR applications is the approval-rate of their submissions. Although this data has been historically unavailable across every federal agency, it is now accessible for the National Institutes of Health (NIH), the second largest provider of SBIR/STTR awards, according to a 2018 Digest report. The NIH distributed $446.2 million in SBIR/STTR awards in 2017, with every state except North and South Dakota receiving an award. Although California and Massachusetts had the most successful SBIR/STTR applications in 2017, accounting for roughly one-third of the total when combined, neither state ranked among the top 10 in success rate. NIH SBIR/STTR applications in Oregon (29 percent success rate), Vermont (25 percent success rate), and Wisconsin (23 percent success rate) were the most likely to be approved over the ten-year period from 2008 to 2017. Each of these states, as well as many others with high success rates, offer assistance with proposals such as technical support programs and Phase 0 grants.

A significant majority of SBIR and STTR grants awarded to small businesses from the National Institutes of Health in any given year end up in just a handful of states.

The administration’s FY 2018 budget request for the Department of Health and Human Services (HHS) is $69.8 billion in discretionary spending, reflecting a $14.6 billion (17.3 percent) decrease from FY 2017 estimated funding levels. Discretionary spending accounts for approximately 7 percent of the total proposed HHS budget. Mandatory spending for programs like Medicare, Medicaid and the Children’s Health Insurance Program account for the balance. Total FY 2018 budget authority for HHS would be $1.1 trillion (0.03 percent increase over FY 2017 estimates).

In Part 1 of this two-part series, SSTI examined NIH’s proposed changes that will place limits on individual researcher funding. In Part 2, impacts of the limits are explored.

In the May 18th Digest, proposed changes to the National Institutes of Health (NIH) grants funding process were highlighted. The changes – tilted the Grant Support Index (GSI) – would impose a general limit of three major grants per researcher. Since the article was published, the NIH’s director, Francis Collins, announced during a U.S. House appropriations subcommittee that NIH intends to proceed with the GSI proposal. In this second part of the series,SSTI reveals areas within the field of tech-based economic development that could see the benefits and/or the negative unintended consequences of these changes.

With final passage and signage pending at the time of publication, the federal budget for FY 2018 provides relatively strong support for innovation economies. The Regional Innovation Strategies program is funded at $21 million, MEP at $140 million and the National Science Foundation at $7.8 billion, increases for all organizations. Other notable innovation programs receiving at least level funding are SBA’s cluster and accelerator programs, DOE’s ARPA-E, NASA science and the National Institutes of Health.

With a focus on improving health, driving economic growth, and expanding the country’s research capacity, the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services is the largest public funder of biomedical research in the world. Because of NIH’s central role in supporting science, technology, and innovation, a better understanding of the agency’s footprint may be helpful to the technology-based economic development practitioner community.

With the visionary language of large federal initiatives like the “Cancer Moonshot” or provocative branding such as “NIH…Turning Discovery into Health®” and the National Institute of Health website further touting “revolutionary ideas often come from unexpected directions,” one might assume an equally ambitious approach is being taken to ensure federal life sciences research is going toward research with the most promise for positive impact and scientific a

After much criticism, the National Institutes of Health (NIH) announced that it will abandon the Grant Support Index (GSI) plan – a strategy to bolster NIH funding support for the next generation of researchers by placing limits on individual research funding which SSTI previously covered.. Instead, NIH will launch the Next Generation Researchers Initiative (NGRI) that will allocate $1.1 billion over the next five years to support nearly 2,400 new grants for early and mid-career researchers whose grant proposals receive high scores, but fall short of receiving funds. At this time, however, there was no immediate promise of where that money would be found, according to an article in the The Chronicle of Higher Education.

SSTI is publishing a series of FY 2019 budget updates to match Congress’s unusually early action. 

Congress has passed a budget for FY 2017 that largely continues support for federal innovation programs and R&D investments. Among the highlights are $17 million for Regional Innovation Strategies (a $2 million increase over FY 2016), level funding of $130 million for the Hollings Manufacturing Extension Partnership and $5 million for SBA’s clusters program. In reviewing dozens of line items, offices that had received significant cuts in the White House’s skinny budget appear to receive some of the largest funding increases (such as the Appalachian Regional Commission, Community Development Block Grant and ARPA-E). However, with the exception of multi-billion dollar increases for Department of Defense R&D, many increases are rather small in terms of overall dollars. This is, at least in part, a reflection of non-defense spending caps rising by only $40 million for FY 2017, limiting the availability of new funds. In this context, science and innovation gains are particularly impressive, with a five percent overall increase for federal R&D that particularly benefits NASA and NIH.